|  Help  |  About  |  Contact Us

Publication : Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation.

First Author  Le Guelte A Year  2012
Journal  J Cell Sci Volume  125
Issue  Pt 17 Pages  4137-46
PubMed ID  22685328 Mgi Jnum  J:198888
Mgi Id  MGI:5499701 Doi  10.1242/jcs.108282
Citation  Le Guelte A, et al. (2012) Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation. J Cell Sci 125(Pt 17):4137-46
abstractText  VE-cadherin-mediated cell-cell junction weakening increases paracellular permeability in response to both angiogenic and inflammatory stimuli. Although Semaphorin 3A has emerged as one of the few known anti-angiogenic factors to exhibit pro-permeability activity, little is known about how it triggers vascular leakage. Here we report that Semaphorin 3A induced VE-cadherin serine phosphorylation and internalisation, cell-cell junction destabilisation, and loss of barrier integrity in brain endothelial cells. In addition, high-grade glioma-isolated tumour-initiating cells were found to secrete Semaphorin 3A, which promoted brain endothelial monolayer permeability. From a mechanistic standpoint, Semaphorin 3A impinged upon the basal activity of the serine phosphatase PP2A and disrupted PP2A interaction with VE-cadherin, leading to cell-cell junction disorganization and increased permeability. Accordingly, both pharmacological inhibition and siRNA-based knockdown of PP2A mimicked Semaphorin 3A effects on VE-cadherin. Hence, local Semaphorin 3A production impacts on the PP2A/VE-cadherin equilibrium and contributes to elevated vascular permeability.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

2 Bio Entities

Trail: Publication

0 Expression